Connect Biopharma Holdings (CNTB)

• Market cap: $163M
• 1 day: -4.47%
• 5 days: 7.75%
• 1 month: 73.75%
• 3 months: 48.66%
• 6 months: 270.07%
• Year to date: 129.75%
• 1 year: 184.25%
• 5 years: -84.96%
• 10 years: -84.96%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62